KME Fundamental Analysis - KME GROUP SPA

Fundamental Rating

KME gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 36 industry peers in the Metals & Mining industry. KME may be in some trouble as it scores bad on both profitability and health. KME does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year KME has reported negative net income.

In the past year KME had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: KME reported negative net income in multiple years.

Of the past 5 years KME 4 years had a positive operating cash flow.

1.2 Ratios

KME has a Return On Assets of -3.14%. This is in the lower half of the industry: KME underperforms 71.79% of its industry peers.

The Return On Equity of KME (-34.02%) is worse than 87.18% of its industry peers.

KME's Return On Invested Capital of 1.20% is on the low side compared to the rest of the industry. KME is outperformed by 71.79% of its industry peers.

KME had an Average Return On Invested Capital over the past 3 years of 1.89%. This is significantly below the industry average of 7.87%.

		Industry Rank	Sector Rank
ROA	-3.14%
ROE	-34.02%
ROIC	1.2%

ROA(3y)-1.25%

ROA(5y)1.2%

ROE(3y)-12.27%

ROE(5y)-4.95%

ROIC(3y)1.89%

ROIC(5y)N/A

1.3 Margins

KME's Operating Margin of 0.96% is on the low side compared to the rest of the industry. KME is outperformed by 76.92% of its industry peers.

In the last couple of years the Operating Margin of KME has declined.

Looking at the Gross Margin, with a value of 27.92%, KME is in line with its industry, outperforming 48.72% of the companies in the same industry.

		Industry Rank	Sector Rank
OM	0.96%
PM (TTM)	N/A
GM	27.92%

OM growth 3YN/A

OM growth 5Y-39.92%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KME is destroying value.

Compared to 1 year ago, KME has more shares outstanding

KME has less shares outstanding than it did 5 years ago.

Compared to 1 year ago, KME has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.83, we must say that KME is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 0.83, KME is not doing good in the industry: 79.49% of the companies in the same industry are doing better.

KME has a debt to FCF ratio of 15.00. This is a negative value and a sign of low solvency as KME would need 15.00 years to pay back of all of its debts.

KME has a Debt to FCF ratio (15.00) which is in line with its industry peers.

A Debt/Equity ratio of 3.00 is on the high side and indicates that KME has dependencies on debt financing.

KME has a Debt to Equity ratio of 3.00. This is amonst the worse of the industry: KME underperforms 92.31% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	3
Debt/FCF	15
Altman-Z	0.83

ROIC/WACC0.12

WACC10.16%

2.3 Liquidity

A Current Ratio of 0.77 indicates that KME may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.77, KME is doing worse than 92.31% of the companies in the same industry.

KME has a Quick Ratio of 0.77. This is a bad value and indicates that KME is not financially healthy enough and could expect problems in meeting its short term obligations.

KME has a worse Quick ratio (0.32) than 94.87% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.77
Quick Ratio	0.32

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

KME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.24%, which is quite impressive.

Looking at the last year, KME shows a quite strong growth in Revenue. The Revenue has grown by 12.62% in the last year.

The Revenue has been growing by 163.60% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)72.24%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%7.55%

Revenue 1Y (TTM)12.62%

Revenue growth 3Y1061.12%

Revenue growth 5Y163.6%

Sales Q2Q%28.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

KME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

KME's Enterprise Value to EBITDA is on the same level as the industry average.

100.00% of the companies in the same industry are more expensive than KME, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	5.49
EV/EBITDA	12.48

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for KME!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KME GROUP SPA

BIT:KME (11/10/2025, 7:00:00 PM)

0.89

0 (-0.45%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.07%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap253.15M

Revenue(TTM)1.79B

Net Income(TTM)-64.93M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)-63.27%

DP-0.05%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.14
P/FCF	5.49
P/OCF	2.66
P/B	1.33
P/tB	N/A
EV/EBITDA	12.48

EPS(TTM)-0.27

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.16

FCFY18.21%

OCF(TTM)0.33

OCFY37.55%

SpS6.3

BVpS0.67

TBVpS-0.91

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.14%
ROE	-34.02%
ROCE	1.61%
ROIC	1.2%
ROICexc	1.35%
ROICexgc	2.56%
OM	0.96%
PM (TTM)	N/A
GM	27.92%
FCFM	2.57%

ROA(3y)-1.25%

ROA(5y)1.2%

ROE(3y)-12.27%

ROE(5y)-4.95%

ROIC(3y)1.89%

ROIC(5y)N/A

ROICexc(3y)2.23%

ROICexc(5y)N/A

ROICexgc(3y)4.95%

ROICexgc(5y)N/A

ROCE(3y)2.52%

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5Y79.58%

ROICexc growth 3YN/A

ROICexc growth 5Y46.15%

OM growth 3YN/A

OM growth 5Y-39.92%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.87

Health

		Industry Rank	Sector Rank
Debt/Equity	3
Debt/FCF	15
Debt/EBITDA	8.7
Cap/Depr	100.74%
Cap/Sales	2.73%
Interest Coverage	0.3
Cash Conversion	144.61%
Profit Quality	N/A
Current Ratio	0.77
Quick Ratio	0.32
Altman-Z	0.83

F-Score5

WACC10.16%

ROIC/WACC0.12

Cap/Depr(3y)57.3%

Cap/Depr(5y)69.14%

Cap/Sales(3y)1.76%

Cap/Sales(5y)10.13%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)72.24%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%7.55%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)12.62%

Revenue growth 3Y1061.12%

Revenue growth 5Y163.6%

Sales Q2Q%28.64%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y195.37%

EBIT growth 3YN/A

EBIT growth 5Y58.36%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-62.16%

FCF growth 3Y16.77%

FCF growth 5YN/A

OCF growth 1Y-34.19%

OCF growth 3Y29.71%

OCF growth 5YN/A

KME GROUP SPA / KME.MI FAQ

What is the fundamental rating for KME stock?

ChartMill assigns a fundamental rating of 2 / 10 to KME.MI.

What is the valuation status for KME stock?

ChartMill assigns a valuation rating of 2 / 10 to KME GROUP SPA (KME.MI). This can be considered as Overvalued.

Can you provide the profitability details for KME GROUP SPA?

KME GROUP SPA (KME.MI) has a profitability rating of 1 / 10.

KME GROUP SPA (KME.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

KME GROUP SPA / KME.MI FAQ

What is the fundamental rating for KME stock?

What is the valuation status for KME stock?

Can you provide the profitability details for KME GROUP SPA?